Defining Lymphoplasmacytic Lymphoma: Does MYD88L265P Define a Pathologically Distinct Entity Among Patients With an IgM Paraprotein and Bone Marrow–Based Low-Grade B-Cell Lymphomas With Plasmacytic Differentiation?
暂无分享,去创建一个
R. Kyle | S. Ansell | M. Gertz | W. Morice | P. Kapoor | W. Gonsalves | E. McPhail | J. Abeykoon | D. Viswanatha | H. Fang | M. Howard | R. King | R. He | P. Greipp | J. Paludo | L. Frederick | R. He